Essilor’s Stellest spectacle lens has been launched in Australia/New Zealand to correct vision and slow myopia progression in children. Clinical trial results show that after two years, Essilor Stellest lenses slow myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.1 While current results are based on children from eight to 13 years, Essilor Stellest lenses can be recommended to children as young as six and up to 16-years-old, as determined by the optometrist.
Stellest lenses use H.A.L.T.2 technology; a constellation of 1,021 lenslets spread on 11 rings creates a volume of signal that slows down the elongation of the eye. Based on scientific publications, EssilorLuxottica research and development experts concluded that a volume of signal has a stronger effect on slowing of myopia progression than a surface signal. The aspherical lenslet design and their arrangement create this targeted effect of volume of non-focussed light in front of the retina, following its shape. In children, whose eyes are still developing, this volume of signal keeps the eye elongation process in check.
Essilor Stellest lenses are designed for children, suitable for a variety of paediatric frames. and complemented by advanced equipment from Essilor Instruments.
References
- Compared to single vision lenses, when worn 12 hours a day. Two-year prospective, controlled, randomised, double-masked clinical trial results on 54 myopic children wearing Stellest lenses compared to 50 myopic children wearing single vision lenses. Efficacy results based on 32 children who declared wearing Stellest lenses at least 12 hours per day every day. Bao J. et al. (2021). Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomised clinical trial. Invest. Ophthalmol. Vis. Sci.; 62(8):2888.
- Highly Aspherical Lenslet Target.
